Type to search

Iain Mackay, Chief Financial Officer, to Retire From GSK, Julie Brown Appointed as Successor | Pharmtech Focus
Zejula (Niraparib) Shows Durable and Sustained Long-term Progression-free Survival Benefit in the Prima Study of First-line Platinum-responsive Advanced Ovarian Cancer | Pharmtech Focus
WHO Grants Prequalification to GSK’s Mosquirix – the First and Only Approved Malaria Vaccine | Pharmtech Focus